Overview
UK consumer healthcare firm's yearly revenue grew 32.2%, driven by Power Brands and acquisitions
Adjusted EPS for the year rose 15.4%, reflecting improved profitability post-divestment
Company launched share buyback in Sept, returning £1.1 mln to shareholders by period end
Outlook
Company says revenues currently trading about 18% ahead of prior year with improved gross margin
Venture Life is pursuing M&A opportunities to drive growth in targeted sectors and geographies
Company expects profitability initiatives and new product launches to support future revenue growth
Result Drivers
POWER BRANDS GROWTH - Revenue growth was driven by strong performance of Power Brands, with Balance Activ, Lift, Earol, and Health & Her/Him all posting gains, especially in the UK
HEALTH & HER ACQUISITION - Integration of Health & Her contributed significant revenue and EBITDA growth, with the brand delivering 44% proforma revenue growth and expanding distribution
HIGHER OPERATING COSTS - Operating expenses rose due to increased advertising and promotional spend and inclusion of costs from the Health & Her acquisition, impacting EBITDA margin
Company press release: ID:nRSe7199Ya
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
GBP 35.20 mln
FY Net Income
GBP 6.10 mln
FY EBIT
-GBP 1.30 mln
FY Gross Profit
GBP 15.80 mln
Analyst Coverage
The one available analyst rating on the shares is "strong buy"
The average consensus recommendation for the pharmaceuticals peer group is "buy."
Wall Street's median 12-month price target for Venture Life Group PLC is GBp100.00, about 47.1% above its March 30 closing price of GBp68.00
The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 11 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)